Abstract:Recombinant activated factor VII (rFVIIa) is a new hemostatic drug, originally used for the treatment of patients with hemophilia A and B. At the present time it is used for other bleeding conditions (Rev Méd Chile 2009; 137: 837-43l Factor VII (FVII) es un potente agente prohemostático. Su uso clínico se ha estudiado desde comienzos de la década 1980-89 1 , pero esos estudios se vieron limitados por la difícil obtención del factor aislado. Fue el lanzamiento de la forma recombinante (rFVII) en 1988 el que fac… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.